Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Physiol
2003 Dec 15;553Pt 3:719-28. doi: 10.1113/jphysiol.2003.050955.
Show Gene links
Show Anatomy links
Potentiation of quantal secretion by insulin-like growth factor-1 at developing motoneurons in Xenopus cell culture.
Liou JC, Tsai FZ, Ho SY.
???displayArticle.abstract???
Although evidence suggests that insulin-like growth factor (IGF) plays an important role in the development and growth of the nervous system, the effect of IGF-1 in the regulation of neurotransmitter release in the peripheral nervous system remains unknown. Here we show that acute application of IGF-1, a factor widely expressed in developing myocytes, dose-dependently enhances the spontaneous acetylcholine (ACh) secretion at developing neuromuscular synapses in Xenopus cell culture using whole-cell patch clamp recording. We studied the role of endogenously released IGF-1 by examining the effect of IGF-1 antibody on the frequency of spontaneous synaptic currents (SSCs) at high-activity synapses, and found SSC frequency was markedly reduced at these high-activity synapses. The IGF-1-induced synaptic potentiation was not abolished when Ca2+ was eliminated from the culture medium or there was bath-application of the pharmacological Ca2+ channel inhibitor Cd2+, indicating that Ca2+ influxes through voltage-activated Ca2+ channels are not required. Application of membrane-permeable inhibitors of inositol 1,4,5-trisphosphate (IP3) or ryanodine receptors effectively occluded the increase of SSC frequency elicited by IGF-I. Treating cells with the phosphoinositide-3 kinase (PI3-K) inhibitors wortmannin or LY294002, and with phospholipase Cgamma (PLCgamma) inhibitor U73122, but not the inhibitor of mitogen-activated protein (MAP) kinase PD98059, abolished IGF-1-induced synaptic potentiation. Taken collectively, these results suggest that endogenously released IGF-1 from myocytes elicits Ca2+ release from IP3- and/or ryanodine-sensitive intracellular Ca2+ stores of the presynaptic nerve terminal. This is done via PI3-K and PLCgamma signalling cascades, leading to an enhancement of spontaneous transmitter release.
Augustine,
Calcium action in synaptic transmitter release.
1987, Pubmed
Augustine,
Calcium action in synaptic transmitter release.
1987,
Pubmed Bae,
Activation of phospholipase C-gamma by phosphatidylinositol 3,4,5-trisphosphate.
1998,
Pubmed Balice-Gordon,
In vivo observations of pre- and postsynaptic changes during the transition from multiple to single innervation at developing neuromuscular junctions.
1993,
Pubmed Bennet,
Neuronal cell death, nerve growth factor and neurotrophic models: 50 years on.
2002,
Pubmed Berridge,
Neuronal calcium signaling.
1998,
Pubmed Black,
Trophic regulation of synaptic plasticity.
1999,
Pubmed Blair,
Akt-dependent potentiation of L channels by insulin-like growth factor-1 is required for neuronal survival.
1999,
Pubmed Blair,
IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner.
1997,
Pubmed Buchanan,
Studies of nerve-muscle interactions in Xenopus cell culture: fine structure of early functional contacts.
1989,
Pubmed
,
Xenbase Caroni,
Activity-sensitive signaling by muscle-derived insulin-like growth factors in the developing and regenerating neuromuscular system.
1993,
Pubmed Caroni,
Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors.
1990,
Pubmed Caroni,
Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4.
1994,
Pubmed Chattopadhyay,
PLC-gamma1 is required for IGF-I protection from cell death induced by loss of extracellular matrix adhesion.
2002,
Pubmed Chow,
Release of acetylcholine from embryonic neurons upon contact with muscle cell.
1985,
Pubmed
,
Xenbase Connor,
Retrograde signaling in the formation and maintenance of the neuromuscular junction.
1994,
Pubmed Dan,
Hebbian depression of isolated neuromuscular synapses in vitro.
1992,
Pubmed
,
Xenbase Davies,
Neurotrophin switching: where does it stand?
1997,
Pubmed Decker,
Calcium permeability of the nicotinic acetylcholine receptor: the single-channel calcium influx is significant.
1990,
Pubmed Delbono,
Regulation of mouse skeletal muscle L-type Ca2+ channel by activation of the insulin-like growth factor-1 receptor.
1997,
Pubmed Evers,
Studies of nerve-muscle interactions in Xenopus cell culture: analysis of early synaptic currents.
1989,
Pubmed
,
Xenbase Falasca,
Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting.
1998,
Pubmed Foncea,
Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes.
1997,
Pubmed Fu,
Potentiation by endogenously released ATP of spontaneous transmitter secretion at developing neuromuscular synapses in Xenopus cell cultures.
1994,
Pubmed
,
Xenbase Funakoshi,
Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons.
1995,
Pubmed Hamill,
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
1981,
Pubmed He,
Intracellular Ca(2+) and Ca(2+)/calmodulin-dependent kinase II mediate acute potentiation of neurotransmitter release by neurotrophin-3.
2000,
Pubmed
,
Xenbase Hong,
Role of phospholipase C-gamma1 in insulin-like growth factor I-induced muscle differentiation of H9c2 cardiac myoblasts.
2001,
Pubmed Ishii,
Relationship of insulin-like growth factor II gene expression in muscle to synaptogenesis.
1989,
Pubmed Kanzaki,
Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I.
1999,
Pubmed Kar,
Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation.
1997,
Pubmed Kar,
Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain.
1993,
Pubmed Kidokoro,
Early cross-striation formation in twitching Xenopus myocytes in culture.
1988,
Pubmed
,
Xenbase Kim,
Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation.
1997,
Pubmed Leski,
Insulin-like growth factor I prevents the development of sensitivity to kainate neurotoxicity in cerebellar granule cells.
2000,
Pubmed Lewis,
Insulin-like growth factor-I: potential for treatment of motor neuronal disorders.
1993,
Pubmed Liou,
Regulation of quantal secretion from developing motoneurons by postsynaptic activity-dependent release of NT-3.
1997,
Pubmed
,
Xenbase Lo,
Activity-dependent synaptic competition in vitro: heterosynaptic suppression of developing synapses.
1991,
Pubmed
,
Xenbase Lutz,
Effects of insulin-like growth factor-1 in motor nerve regeneration after nerve transection and repair vs. nerve crushing injury in the rat.
1999,
Pubmed Mehrhof,
In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein.
2001,
Pubmed Miledi,
Transmitter release induced by injection of calcium ions into nerve terminals.
1973,
Pubmed Mothet,
Cyclic ADP-ribose and calcium-induced calcium release regulate neurotransmitter release at a cholinergic synapse of Aplysia.
1998,
Pubmed Poo,
Neurotrophins as synaptic modulators.
2001,
Pubmed Pu,
Insulin-like growth factor-II increases and IGF is required for postnatal rat spinal motoneuron survival following sciatic nerve axotomy.
1999,
Pubmed Renganathan,
Overexpression of hIGF-1 exclusively in skeletal muscle increases the number of dihydropyridine receptors in adult transgenic mice.
1997,
Pubmed Rhee,
Regulation of phosphoinositide-specific phospholipase C.
2001,
Pubmed Sanes,
Development of the vertebrate neuromuscular junction.
1999,
Pubmed Seto,
Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects.
2002,
Pubmed Smith,
Ryanodine-sensitive calcium stores involved in neurotransmitter release from sympathetic nerve terminals of the guinea-pig.
1996,
Pubmed Streppel,
Focal application of neutralizing antibodies to soluble neurotrophic factors reduces collateral axonal branching after peripheral nerve lesion.
2002,
Pubmed Takahashi,
Structure and physiology of developing neuromuscular synapses in culture.
1987,
Pubmed
,
Xenbase Tempia,
Characterization of the mGluR(1)-mediated electrical and calcium signaling in Purkinje cells of mouse cerebellar slices.
2001,
Pubmed Vergani,
Systemic administration of insulin-like growth factor decreases motor neuron cell death and promotes muscle reinnervation.
1998,
Pubmed Wang,
Potentiation of developing synapses by postsynaptic release of neurotrophin-4.
1997,
Pubmed
,
Xenbase Xie,
Initial events in the formation of neuromuscular synapse: rapid induction of acetylcholine release from embryonic neuron.
1986,
Pubmed
,
Xenbase Xie,
Activity-dependent expression of NT-3 in muscle cells in culture: implications in the development of neuromuscular junctions.
1997,
Pubmed
,
Xenbase
